BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31809341)

  • 1. Proton-pump Inhibitor Use and Myocardial Infarction: A Nested Case-Control Study in the UK Clinical Practice Research Datalink.
    Qian Y; Jick S
    Epidemiology; 2020 May; 31(3):423-431. PubMed ID: 31809341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink.
    Baak BN; Jick SS
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):58-75. PubMed ID: 35876661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
    Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
    Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series.
    Chui CSL; Cheung KS; Brown JP; Douglas IJ; Wong ICK; Chan EW; Wong AYS
    Int J Epidemiol; 2023 Jun; 52(3):899-907. PubMed ID: 36259933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
    Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
    J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.
    Tran KT; McMenamin ÚC; Hicks B; Murchie P; Thrift AP; Coleman HG; Iversen L; Johnston BT; Lee AJ; Cardwell CR
    Aliment Pharmacol Ther; 2018 Jul; 48(1):55-64. PubMed ID: 29741272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of proton pump inhibitors and risk of ischemic events in the general population.
    Casula M; Scotti L; Galimberti F; Mozzanica F; Tragni E; Corrao G; Catapano AL
    Atherosclerosis; 2018 Oct; 277():123-129. PubMed ID: 30212680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
    Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
    Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
    Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.
    Simon T; Steg PG; Gilard M; Blanchard D; Bonello L; Hanssen M; Lardoux H; Coste P; Lefèvre T; Drouet E; Mulak G; Bataille V; Ferrières J; Verstuyft C; Danchin N
    Circulation; 2011 Feb; 123(5):474-82. PubMed ID: 21262992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
    Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
    Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
    García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
    Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
    Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
    J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors on pancreatic cancer risk and survival.
    Kearns MD; Boursi B; Yang YX
    Cancer Epidemiol; 2017 Feb; 46():80-84. PubMed ID: 28056391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case-Control Study.
    Farhat N; Birkett N; Haddad N; Fortin Y; Momoli F; Wen SW; Wielgosz A; McNair DS; Mattison DR; Krewski D
    Drugs Real World Outcomes; 2020 Sep; 7(3):191-203. PubMed ID: 32617885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
    Ngwenya S; Simin J; Brusselaers N
    Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
    Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
    Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.